StopDownOpen the app

New fund · Healthcare & Life Sciences

W Health Ventures closes Fund II at ₹700 crore to build healthcare companies

By ·

Date
Company
W Health Ventures
What it does
healthcare company creation fund
Kind
New fund
Amount
Rs 700 crore
Stage
growth
Based in
Mumbai
Founded
2020
Sector
Healthcare & Life Sciences

What they do

W Health Ventures is a healthcare company creation fund that builds businesses from pre-idea to category leadership in India and the US-India corridor

What happened

The firm closed its second fund at ₹700 crore, exceeding its initial target of ₹630 crore, and plans to build 8–10 healthcare companies over the next four years

Why it matters

W Health Ventures has deployed $65 million across 14 portfolio companies, reaching over 25 million patients, and has launched two new companies: Everhope…

The details

  • W Health Ventures has closed its second fund at ₹700 crore, exceeding its initial target of ₹630 crore.
  • Fund II will be used to build 8–10 healthcare companies over the next four years, taking them from the pre-idea stage to category leaders.
  • W Health Ventures follows a company-creation model, where its in-house team of physicians, operators, and technologists identifies gaps in healthcare delivery.
  • The firm spends 12–18 months evaluating and de-risking opportunities before bringing in a founding team.
  • Fund II plans to invest ₹30–50 crore in each company and build 2–3 companies every year across India and the US-India corridor.
  • Everhope Oncology and Everbright Health are the first two companies launched under Fund II.
  • Everhope Oncology was built in partnership with Narayana Health and focuses on coordinated, patient-centric cancer care.
  • Everbright Health is being developed in the US and focuses on treatments for treatment-resistant depression.
  • W Health Ventures has deployed $65 million across 14 portfolio companies, reaching over 25 million patients.
  • The firm has built companies including Elevate Now, Nivaan Care, Hoola Health, and Everhope Oncology.

The bigger picture

  • W Health Ventures focuses on building healthcare companies in areas with significant gaps in healthcare delivery.
  • The firm believes that the rising demand and constrained supply in healthcare create opportunities for new companies.
  • W Health Ventures is part of a broader shift among venture investors towards company creation, where firms identify problems and assemble founding teams.
  • The firm operates from Boston, Delhi, Mumbai, and Bengaluru.
  • W Health Ventures has raised ₹700 crore for Fund II, with family offices and institutional investors from India and the US as limited partners.

About the business

  • W Health Ventures is a healthcare company creation fund that builds businesses from pre-idea to category leadership.
  • The firm operates in India and the US-India corridor, focusing on healthcare delivery gaps.
  • W Health Ventures has deployed $65 million across 14 portfolio companies, reaching over 25 million patients.
  • The firm has built companies including Elevate Now, Nivaan Care, Hoola Health, and Everhope Oncology.
  • W Health Ventures has launched two new companies under Fund II: Everhope Oncology and Everbright Health.

What happens next

  • W Health Ventures plans to build 8–10 healthcare companies over the next four years.
  • The firm will focus on solving large, underserved healthcare problems where first-mover solutions can create impact at population scale.
  • W Health Ventures will invest ₹30–50 crore in each company and build 2–3 companies every year.

The deal

Type
fund

Investors

  • Family Offices (limited partners) — Family offices from India and the US are limited partners in Fund II.
  • Institutional Investors (limited partners) — Institutional investors from India and the US are limited partners in Fund II.

Founders

  • Pankaj Jethwani, managing partner
  • Sunil Wadhwani, founder

Other articles talking about it

Read it as a card in the app

More on W Health Ventures

Everything on W Health Ventures →

Same day

All startup news on 8 September 2026 →